VAIBHAVI P MUKHTIAR

Allopathic & Osteopathic Physicians|Internal Medicine WORCESTER, MA NPI 1689351504

General Payments — all program years on this page

$972.65

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 38
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $518.67 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $518.6721

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $453.9817
2024 $518.6721

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086166728 Bayer Healthcare Pharmaceuticals Inc. $25.87 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086212633 Bayer Healthcare Pharmaceuticals Inc. $16.92 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086235136 Bayer Healthcare Pharmaceuticals Inc. $14.76 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101343299 E.R. Squibb & Sons, L.L.C. $25.13 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104562784 AstraZeneca Pharmaceuticals LP $20.91 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105078829 ABBVIE INC. $33.70 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105078831 ABBVIE INC. $30.41 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105078833 ABBVIE INC. $25.93 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105078835 ABBVIE INC. $33.83 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105078837 ABBVIE INC. $31.21 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105078839 ABBVIE INC. $29.96 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105358718 AstraZeneca Pharmaceuticals LP $23.53 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105421613 AstraZeneca Pharmaceuticals LP $22.00 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124755766 Grifols USA, LLC $34.58 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124755768 Grifols USA, LLC $29.20 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125849994 Alnylam Pharmaceuticals Inc. $22.33 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131398854 PFIZER INC. $14.04 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137639318 Takeda Pharmaceuticals U.S.A., Inc. $23.02 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137639320 Takeda Pharmaceuticals U.S.A., Inc. $20.94 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145537817 Karyopharm Therapeutics Inc. $18.91 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146952088 Fresenius Kabi USA, LLC $21.49 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.